Vimarsana
Biggest News Aggregation in the World

Page 9 - Therapeutic Development Programs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Therapeutic Development Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Therapeutic Development Programs Today - Breaking & Trending Today

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Coverage Initiated at StockNews.com - Vimarsana News

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a research note released on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Stock Performance NAVB stock opened at $0.09 on Monday. Navidea Biopharmaceuticals has a one year low of $0.07 and a one year […]

Source: wkrb13.com
Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Now Covered by StockNews.com - Vimarsana News

Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Now Covered by StockNews.com

StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a research note issued to investors on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Stock Up 7.9 % NYSEAMERICAN:NAVB opened at $0.09 on Friday. The stock’s fifty day moving average is $0.17 and its two-hundred […]

Source: wkrb13.com
Navidea Biopharmaceuticals (NYSE:NAVB) Earns Sell Rating from Analysts at StockNews.com - Vimarsana News

Navidea Biopharmaceuticals (NYSE:NAVB) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) in a research note issued to investors on Saturday. The firm set a “sell” rating on the stock. Navidea Biopharmaceuticals Price Performance Navidea Biopharmaceuticals Company Profile (Get Rating) Navidea Biopharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic […]

Alpha Teknova (NASDAQ:TKNO) versus Navidea Biopharmaceuticals (NYSE:NAVB) Financial Analysis - Vimarsana News

Alpha Teknova (NASDAQ:TKNO) versus Navidea Biopharmaceuticals (NYSE:NAVB) Financial Analysis

Alpha Teknova (NASDAQ:TKNO – Get Rating) and Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, analyst recommendations, valuation and dividends. Earnings & Valuation This table compares Alpha Teknova and […]

Navidea Biopharmaceuticals (NYSE:NAVB) Now Covered by Analysts at StockNews.com - Vimarsana News

Navidea Biopharmaceuticals (NYSE:NAVB) Now Covered by Analysts at StockNews.com

Equities researchers at StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Rating) in a research report issued to clients and investors on Friday. The brokerage set a “sell” rating on the stock. Shares of NAVB stock opened at $0.69 on Friday. The firm has a 50 day moving average of $0.81. Navidea […]